Dexamethasone suppression test in patients with Parkinson's disease
✍ Scribed by Dr. Vladimir S. Kostić; Nadežda Čovičković-Šternić; Ljiljana Beslać-Bumbaširević; Gordana Ocić; Dragan Pavlović; Milisav Nikolić
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 337 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).
📜 SIMILAR VOLUMES
The performance of the Dexamethasone Suppression Test (DST) was investigated in 60 demented patients including 14 patients admitted to a psychogeriatric assessment ward, 29 electively admitted patients and 17 long-stay patients in comparison with 37 normal control subjects. It was shown that acutely
## Objective: To compare the prevalence of fatigue in patients with parkinson's disease (pd) with that in healthy elderly people and to explore the suggestion that fatigue is an independent symptom of pd. ## Design: Questionnaire survey. ## Setting: Community-based population. ## Patients and
Parkinson's disease (PD) is a disabling neurodegenerative condition commonly complicated by the existence of comorbid depression. The prevalence rates of depression in this patient group have been reported to be as high as 40%. Currently, depression in PD is undertreated; there have been few control